LOS ANGELES, CA October 11, 2021, Marijuana Company of America, Inc. Reprinted from a previous release 9/21/22
a diversified holding company with operations and investments throughout the cannabis industry, today
announced that the Company’s new hempSMART” Brazil operations has received product recognition from ANVISA,
the Brazilian regulatory agency equivalent to the FDA to sell its premium hempSMART” products via physician prescriptions in Brazil, the biggest CBD market in South America.
The Company has begun to fulfill prescriptions and expects continued requests. ANVISA, the Brazilian regulatory agency,
in 2019 established a legalized environment for the sale and consumption of CBD and cannabis for medical use in Brazil.
ANVISA Agência Nacional de Vigilância Sanitária
ANVISA is an autonomous agency that regulates most, if not all products and services in Brazil.
The institution assures that products follow the necessary standards and health regulations
before they can be sold to patients. hempSMART” products are available to physicians and patients in Brazil.
The ANVISA regulatory framework sets a comprehensive procedure for the manufacture and import of CBD products as well as the requirements
for commercialization, prescription, dispensing, monitoring and supervision of cannabis products for medical purposes.
Cannabidiol (CBD) oil can be sold only in Brazil to cannabis medical patients who receive a special control prescription from their physician,
and must be renewed every 60 days. hempSMART” is now being shipped directly to the patient.
4 Hemp Club was Inspired by Steven Smith’s vision to
“Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
1 thought on “MCOA’s New hempSMART” Brazil Operations Has Received Product Recognition From ANVISA – (USA version of FDA)”
You must log in to post a comment.